The gene editing technologies market is driven by technological advancements enhancing precision, expanding applications in ...

When UC Berkeley biochemist Jennifer Doudna first began studying how bacteria fight virus infections, she had no idea it ...

If approved, Regeneron and Tessera's TSRA-196 could become the first curative therapy to reach patients with AATD, who have ...

Bio-Gene Technology Ltd. ( ($AU:BGT) ) has provided an announcement. Bio-Gene Technology Limited has completed a review of its continuous ...

The market offers strong growth potential driven by advancements in genetic engineering for efficient pharmaceutical protein ...

A new FDA pathway could speed bespoke gene therapies, but key questions over scope and commercial viability remain.

The global cell culture microcarriers market size was valued at USD 3.18 billion in 2024 and is predicted to hit around USD 7 ...

Pharmaceutical companies face distinct pricing and market access (P&MA) challenges in Korea and Australia, two of ...

Selecting corn genetics isn’t a decision to take lightly. Managing nitrogen with the same care helps protect yield potential ...

SGT-212 has been granted FDA Rare Pediatric Disease and Fast Track designations - - SGT-212 is the only dual route gene therapy in development to treat Friedreich’s ataxia - CHARLESTOWN, Mass., Dec.

CNW/ - CCRM and CCRM Nordic AB have announced a strategic collaboration with IonQ, a global leader in quantum computing ...

Steel Dynamics, Inc. today announced its completion of the acquisition of the remaining 55% equity interest in New Process Steel, L.P. ("New Process Steel" or "New Process"). New Process Steel is a ...